Search research articles
Contact Us
Filters
Showing results (201-210 of 219) with videos related to
Page
of 22
Sort By:
JAMA Network Open
|
April 9, 2025
Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases
Eugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.
The Lancet. Oncology
|
November 27, 2025
Neurocognitive outcomes in patients with brain metastases: a systematic review
Tarek Bou Dargham, Sebastian F Winter, Kristen Batich, et al.
Neuro-Oncology Advances
|
July 7, 2022
Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases
Matthew M Grabowski, Ethan S Srinivasan, Eugene J Vaios, et al.
Advances in Radiation Oncology
|
December 22, 2021
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
Grace J Kim, Evan D Buckley, James E Herndon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
Practical Radiation Oncology
|
July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
Lia M Halasz, Albert Attia, Lisa Bradfield, et al.
Practical Radiation Oncology
|
June 27, 2025
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline
Debra Nana Yeboa, Steve E Braunstein, Alvin Cabrera, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 219) with videos related to
Sort By:
Page
of 22
JAMA Network Open
|
April 9, 2025
Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases
Eugene J Vaios, Rachel F Shenker, Peter G Hendrickson, et al.
The Lancet. Oncology
|
November 27, 2025
Neurocognitive outcomes in patients with brain metastases: a systematic review
Tarek Bou Dargham, Sebastian F Winter, Kristen Batich, et al.
Neuro-Oncology Advances
|
July 7, 2022
Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases
Matthew M Grabowski, Ethan S Srinivasan, Eugene J Vaios, et al.
Advances in Radiation Oncology
|
December 22, 2021
Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
Grace J Kim, Evan D Buckley, James E Herndon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2017
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 20, 2017
The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases
Paul W Sperduto, Wen Jiang, Paul D Brown, et al.
Practical Radiation Oncology
|
July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
Lia M Halasz, Albert Attia, Lisa Bradfield, et al.
Practical Radiation Oncology
|
June 27, 2025
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline
Debra Nana Yeboa, Steve E Braunstein, Alvin Cabrera, et al.
JAMA Oncology
|
November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Page
of 22